Mira Introduces Ultra4tm, The First At-Home Hormone Monitor With Lab-Quality 4-In-1 Testing
SAN FRANCISCO, Aug. 25, 2025 /PRNewswire/ -- Mira , a leading hormonal health company, launches Ultra4TM, the first at-home hormone monitor to deliver lab-quality insights into four key hormones (FSH, LH, E3G, and PdG) with just one wand and a 16-minute test. For the first time, people can see their full cycle story - from ovulation strength to hormonal balance - with the same precision once only available in clinics.
The new kit measures FSH, LH, E3G, and PdG together - offering a complete hormonal profile across the cycle. This helps users identify imbalances, track shifts over time, and better understand fertility, perimenopause, and overall cycle health. Ultra4 is the only tracker on the market powered by fluorescent technology – the same used in clinical laboratories – and offers up to seven times the accuracy of other fertility trackers on the market. With Mira's AI-powered app, users can test any day of their cycle, or multiple times daily, for personalized insights.
New features include:
-
4D Ovulation ProfilingTM – Assesses not just ovulation timing, but its strength and viability
Egg Prep ScanTM – Shows follicle development early in the cycle
Hormonal FingerprintTM – Builds a personal baseline to flag imbalances
Cycle Balance Analysis – Evaluates hormone ratios for overall harmony
Egg Count IntelligenceTM – Tracks FSH for at-home insights into ovarian reserve
"When we launched Mira, it was with one hormone and one goal: help women understand fertility," said Sylvia Kang, CEO and Co-founder. "Ultra4 is our answer to deeper questions about cycles, egg quality, and hormonal health."
Ultra4 represents Mira's effort to address a persistent blind spot in women's health: the lack of accessible, continuous hormone data. Mira's mission extends beyond fertility to creating a comprehensive hormone health platform that tracks key markers like cortisol, testosterone. The company is developing wearable tech to bring real-time, multi-hormone monitoring into everyday life, transforming hormone data into vital signs for personalized health.
About Mira
Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing Mira was founded in late 2015 with a mission to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives – from the menstrual stage to menopause.
For more information on Mira, please visit miracare .
SOURCE Quanovate Tech Inc, dba Mira
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Industry Leader The5ers Expands Funding Programs To U.S. Traders
- Excellion Finance Scales Market-Neutral Defi Strategies With Fordefi's MPC Wallet
- Xfunded Expands In Dubai, Strengthening Collaborations With Trading Influencers Across Europe
- Chaingpt Pad Unveils Buzz System: Turning Social Hype Into Token Allocation
- PLPC-DBTM: Non-Cellular Oncology Immunotherapy With STIPNAM Traceability, Entering A Global Acquisition Window.
- Thrivestate Launches“Fly Before You Buy” Program, Enabling International Buyers To Explore Dubai Before Committing
Comments
No comment